Brief: Supernus Announces Second Quarter 2022 Financial Results
Aug 4 (Reuters) - Supernus Pharmaceuticals Inc SUPN.O :
* SUPERNUS ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS
* Q2 2022 TOTAL REVENUES OF $170.1 MILLION, A 20% INCREASE COMPARED TO Q2
2021
* QTRLY EARNINGS PER SHARE $0.14
* SEES 2022 TOTAL REVENUES IN THE RANGE OF $640 MILLION - $680 MILLION
* Q2 EARNINGS PER SHARE VIEW $0.29 -- REFINITIV IBES DATA
* Q2 REVENUE VIEW $164.2 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX5LY5V1
Further company coverage: SUPN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Supernus Pharmaceuticals
See all newsHuron Consulting poised to hit fresh record ahead of S&P SmallCap addition
Brief: S&P Dow Jones Indices Msg Rangers And Huron Consulting Group Set To Join S&P Smallcap 600
Brief: Supernus Pharmaceuticals Says FDA Grants Seven Years Orphan-Drug Exclusivity For Onapgo
Supernus Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE -Micron Technology, Ares Management, Boeing